Dosing schedules and outcomes in patients with first-line sunitinib for advanced renal cell carcinoma
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma | NEJM
Overall survival for first-line IO combination therapies. CI =... | Download Scientific Diagram
PTEN Is Involved in Sunitinib and Sorafenib Resistance in Renal Cell Carcinoma | Anticancer Research
Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response ...
Experience with sunitinib in the treatment of metastatic renal cell carcinoma - Manuela Schmidinger, James Larkin, Alain Ravaud, 2012
Management of adverse events associated with cabozantinib plus nivolumab in renal cell carcinoma: A review - ScienceDirect
a) Progression-free survival (PFS) in 90 mRCC patients treated with... | Download Scientific Diagram
Long-term response to sunitinib: everolimus treatment in metastatic clear cell renal cell carcinoma | Future Oncology
5-year Follow-Up: First-Line Nivolumab Plus Ipilimumab vs Sunitinib in Advanced Renal Cell Carcinoma - Cancer Therapy Advisor
Plasma cytokine and angiogenic factors associated with prognosis and therapeutic response to sunitinib vs everolimus in advanced non-clear cell renal cell... | Oncotarget
Sunitinib re-challenge in advanced renal-cell carcinoma | British Journal of Cancer
Overall survival rates of advanced gastrointestinal stromal tumor... | Download Scientific Diagram
Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers | BMC Cancer | Full Text
Survival Benefits of Second-line Axitinib Versus Everolimus After First Line Sunitinib Treatment in Metastatic Renal Cell Carcinoma | SpringerLink
IJMS | Free Full-Text | A New Signature That Predicts Progression-Free Survival of Clear Cell Renal Cell Carcinoma with Anti-PD-1 Therapy
Sunitinib effectiveness and safety as first line treatment in metastatic renal cell carcinoma, in the Costa Rican population
Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers | BMC Cancer | Full Text
Long-term response to sunitinib: everolimus treatment in metastatic clear cell renal cell carcinoma | Future Oncology
Cancers | Free Full-Text | Progression-Free and Overall Survival of First- Line Treatments for Advanced Renal Cell Carcinoma: Indirect Comparison of Six Combination Regimens
Sunitinib effectiveness and safety as first line treatment in metastatic renal cell carcinoma, in the Costa Rican population
Frontiers | Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation
Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting | Future Oncology
Overall survival with sorafenib and sunitinib compared with other... | Download Scientific Diagram
Updated Efficacy and Safety Outcomes for Patients with Well-Differentiated Pancreatic Neuroendocrine Tumors Treated with Sunitinib | SpringerLink
